Usefulness of Fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes (from the French Registry of Acute ST-elevation non-ST-elevation myocardial infarction [FAST-MI])

American Journal of Cardiology

Volumn 111, Issue 1, 2013, Pages 31-37

  Lim, Pascal ^a   Moutereau, Stephane ^a   Simon, Tabassome ^e   Gallet, Romain ^a   Probst, Vincent ^c   Ferrieres, Jean ^b   Gueret, Pascal ^a   Danchin, Nicolas ^d  

^a HENRI MONDOR HOSPITAL   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; CREATINE KINASE; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FETUIN A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BODY MASS; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; DISEASE REGISTRY; FEMALE; GLOBAL REGISTRY OF ACUTE CORONARY EVENTS RISK SCORE; HEART MUSCLE NECROSIS; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ACUTE CORONARY SYNDROME; AGED; ALPHA-2-HS-GLYCOPROTEIN; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; FRANCE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; REGISTRIES; SURVIVAL RATE;

EID: 84871014076     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.08.042     Document Type: Article

References (29)

1. G.K. Chalikias, D.N. Tziakas, J.C. Kaski, E.I. Hatzinikolaou, D.A. Stakos, I.K. Tentes, A. Kortsaris, and D.I. Hatseras Interleukin-18: interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome Atherosclerosis 182 2005 135 143
2. T. Kilic, D. Ural, E. Ural, Z. Yumuk, A. Agacdiken, T. Sahin, G. Kahraman, G. Kozdag, A. Vural, and B. Komsuoglu Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome Heart 92 2006 1041 1046
3. C. Heeschen, S. Dimmeler, C.W. Hamm, S. Fichtlscherer, E. Boersma, M.L. Simoons, and A.M. Zeiher Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes Circulation 107 2003 2109 2114
4. J.P. Lebreton, F. Joisel, J.P. Raoult, B. Lannuzel, J.P. Rogez, and G. Humbert Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant J Clin Invest 64 1979 1118 1129
5. M. Ombrellino, H. Wang, H. Yang, M. Zhang, J. Vishnubhakat, A. Frazier, L.A. Scher, S.G. Friedman, and K.J. Tracey Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan Shock 15 2001 181 185
6. H. Wang, M. Zhang, M. Bianchi, B. Sherry, A. Sama, and K.J. Tracey Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules Proc Natl Acad Sci U S A 95 1998 14429 14434
7. P. Lim, J.P. Collet, S. Moutereau, N. Guigui, L. Mitchell-Heggs, S. Loric, M. Bernard, S. Benhamed, G. Montalescot, J.L. Rande, and P. Gueret Fetuin-A is an independent predictor of death after ST-elevation myocardial infarction Clin Chem 53 2007 1835 1840
8. M. Ketteler, P. Bongartz, R. Westenfeld, J.E. Wildberger, A.H. Mahnken, R. Bohm, T. Metzger, C. Wanner, W. Jahnen-Dechent, and J. Floege Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study Lancet 361 2003 827 833
9. P. Stenvinkel, K. Wang, A.R. Qureshi, J. Axelsson, R. Pecoits-Filho, P. Gao, P. Barany, B. Lindholm, T. Jogestrand, O. Heimbürger, C. Holmes, M. Schalling, and L. Nordfors Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin Kidney Int 67 2005 2383 2392
10. J. Ren, and A.J. Davidoff α2-Heremans Schmid glycoprotein, a putative inhibitor of tyrosine kinase, prevents glucose toxicity associated with cardiomyocyte dysfunction Diabetes Metab Res Rev 18 2002 305 310
11. M.W. Merx, C. Schafer, R. Westenfeld, V. Brandenburg, S. Hidajat, C. Weber, M. Ketteler, and W. Jahnen-Dechent Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-a-deficient mice J Am Soc Nephrol 16 2005 3357 3364
12. H. Wang, W. Li, S. Zhu, J. Li, J. D'Amore, M.F. Ward, H. Yang, R. Wu, W. Jahnen-Dechent, K.J. Tracey, P. Wang, and A.E. Sama Peripheral administration of fetuin-A attenuates early cerebral ischemic injury in rats J Cereb Blood Flow Metab 30 2010 493 504
13. J.H. Ix, M.G. Shlipak, V.M. Brandenburg, S. Ali, M. Ketteler, and M.A. Whooley Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study Circulation 113 2006 1760 1767
14. C. Weikert, N. Stefan, M.B. Schulze, T. Pischon, K. Berger, H. Joost, H. Häring, H. Boeing, and A. Fritsche Plasma fetuin-A levels and the risk of myocardial infarction and ischemic stroke Circulation 118 2008 2555 2562
15. N. Stefan, A.M. Hennige, H. Staiger, J. Machann, F. Schick, S.M. Krober, F. Machicao, A. Fritsche, and H.U. Haring Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans Diabetes Care 29 2006 853 857
16. G. Laughlin, K. Cummins, C. Wassel, L. Daniels, and I. JH The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo study J Am Coll Cardiol 59 2012 1688 1696
17. A.M. Hennige, H. Staiger, C. Wicke, F. Machicao, A. Fritsche, H. Häring, and N. Stefan Fetuin-A induces cytokine expression and suppresses adiponectin production PLoS One 3 2008 e1765
18. J.P. Cambou, T. Simon, G. Mulak, V. Bataille, and N. Danchin The French Registry of Acute ST Elevation or Non-ST-Elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics Arch Mal Coeur Vaiss 100 2007 524 534
19. K.A. Eagle, M.J. Lim, O.H. Dabbous, K.S. Pieper, R.J. Goldberg, F. Van de Werf, S.G. Goodman, C.B. Granger, P.G. Steg, J.M. Gore, A. Budaj, A. Avezum, M.D. Flather, K.A. Fox GRACE Investigators A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry JAMA 291 2004 2727 2733
20. P. Theroux, P.W. Armstrong, K.W. Mahaffey, J.S. Hochman, K.J. Malloy, S. Rollins, J.C. Nicolau, J. Lavoie, T.M. Luong, J. Burchenal, and C.B. Granger Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial Eur Heart J 26 2005 1964 1970
21. D.N. Tziakas, G.K. Chalikias, J.C. Kaski, A. Kekes, E.I. Hatzinikolaou, D.A. Stakos, I.K. Tentes, A.X. Kortsaris, and D.I. Hatseras Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach Atherosclerosis 193 2007 196 203
22. A. Abbate, E. Bonanno, A. Mauriello, R. Bussani, G.G. Biondi-Zoccai, G. Liuzzo, A.M. Leone, F. Silvestri, A. Dobrina, F. Baldi, F. Pandolfi, L.M. Biasucci, A. Baldi, L.G. Spagnoli, and F. Crea Widespread myocardial inflammation and infarct-related artery patency Circulation 110 2004 46 50
23. M. Nian, P. Lee, N. Khaper, and P. Liu Inflammatory cytokines and postmyocardial infarction remodeling Circ Res 94 2004 1543 1553
24. J.H. Ix, G.M. Chertow, M.G. Shlipak, V.M. Brandenburg, M. Ketteler, and M.A. Whooley Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study Circulation 115 2007 2533 2539
25. R.A. Kelly, and T.W. Smith Cytokines and cardiac contractile function Circulation 95 1997 778 781
26. K.A. Krown, K. Yasui, M.J. Brooker, A.E. Dubin, C. Nguyen, G.L. Harris, P.M. McDonough, C.C. Glembotski, P.T. Palade, and R.A. Sabbadini TNF alpha receptor expression in rat cardiac myocytes: TNF alpha inhibition of L-type Ca2+ current and Ca2+ transients FEBS Lett 376 1995 24 30
27. P. Libby, P.R. Maroko, C.M. Bloor, B.E. Sobel, and E. Braunwald Reduction of experimental myocardial infarct size by corticosteroid administration J Clin Invest 52 1973 599 607
28. E. Fisher, N. Stefan, K. Saar, D. Drogan, M.B. Schulze, A. Fritsche, H.G. Joost, H.U. Haring, N. Hubner, H. Boeing, and C. Weikert Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study Circ Cardiovasc Genet 2 2009 607 613
29. P.R. Srinivas, A.S. Wagner, L.V. Reddy, D.D. Deutsch, M.A. Leon, A.S. Goustin, and G. Grunberger Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level Mol Endocrinol 7 1993 1445 1455